Vivani Medical News and Activities

Vivani Medical is a company listed under the stock ticker VANI (US).

View the org chart displaying its 22 main executives

Most searched biographies at Vivani Medical

• Adam Mendelsohn, Chief Executive Officer
• Alexandra Popoff, Director
• Aaron Mendelsohn, Director

Popular executive movements at Vivani Medical

• August Moretti has joined the company as Director  (posted on June 26 2026).
• Dean Baker, Director, has left the company  (posted on June 26 2026).

Create your alert
to follow the executive moves at Vivani Medical.

Vivani Medical has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Vivani Medical

• Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
• Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
• Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
• Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
• Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
• Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
• Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
• Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
• Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026
• Vivani Medical, Inc. Announces Closing of Common Stock Offering
• View more press releases Close

Social media about Vivani Medical

• Vivani Medical on Wikipedia, Google News & Yahoo Finance
• Vivani Medical on LinkedIn, X (Twitter) & YouTube